ClinicalTrialsFinder

Patient With Insufficient Response Chemoimmunotherapy Clinical Trials in Aarau

1 recruitingAarau, Switzerland

Showing 1–1 of 1 trials

Recruiting
Phase 3

High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

High Risk NeuroblastomaPatient With Insufficient Response Chemoimmunotherapy
Gustave Roussy, Cancer Campus, Grand Paris800 enrolled142 locationsNCT04221035